<DOC>
	<DOC>NCT00632814</DOC>
	<brief_summary>A prospective study to evaluate the effect of rFVIII-FS in different prophylactic regimens on bleeding events frequency and development of arthropathy in Previously Treated and Minimally treated Hemophilia A pediatric population.</brief_summary>
	<brief_title>Russian Kogenate Pediatric Study</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Male Severe hemophilia A or moderate hemophilia A 112 years of age Requiring treatment with FVIII Current or prior inhibitor or familial antecedents of inhibitor Surgery required during the study (9 months) Positive for HIV</criteria>
	<gender>Male</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Kogenate,</keyword>
	<keyword>Children,</keyword>
	<keyword>Factor VIII,</keyword>
	<keyword>Hemophilia A,</keyword>
	<keyword>Prophylactic</keyword>
</DOC>